Synthesizing DNA, David Goeddel
Interviewee: David Goeddel. David Goeddel talks about the strategy Genentech used in making synthetic insulin. (DNAi Location: Manipulation > Production > Players > David Goeddel > The Genentech way)
And in those days fragments of DNA up to, say, twenty nucleotides could be synthesized. DNA comes as a, is double-stranded so you need two complementary strands to make a functional molecule. Chemically you synthesize them only as a single strand and then you synthesize the complementary strand, and you stitch them together in pieces using various enzymes to hook them together, actually make the connections. Quite different than isolating a natural gene or various enzymatic tricks to make a copy of a natural gene. Very few labs that could do it, there were a few, and I felt when I was a chemist doing it, it was actually very boring chemistry. Took a long time, things could go wrong, and it was a great advantage Genentech had early, was having Keiichi Itakura with a lab that was really good at doing this.
functional molecule,dna synthesis,complementary strands,complementary strand,dnai,genentech,keiichi,interviewee,nucleotides,enzymes,chemist,insulin,fragments,manipulation,chemistry,long time,david goeddel
David Goeddel was one of the first scientists Herb Boyer hired for the insulin project. Here, David Goeddel talks about Genentech's general strategy for synthesizing insulin.
Fred Sanger outlines DNA sequencing.
David Goeddel talks about how another group was trying to make insulin.
DNAFTB Animation 31: Roy Britten presents his work with David Kohne on repetitive DNA and its evolutionary origins.
DNA polymerase and an experiment using nitrogen isotopes prove DNA replication.
David Goeddel talks about what it was like to work at Genetech during its early days.
The cycles of the polymerase chain reaction (PCR).
In 1980, Genentech became the first publicly traded biotech company. David Goeddel talks about his investment.
David Goeddel talks about the other groups working on the insulin problem.
Stanley Cohen and Herbert Boyer transform bacteria with a recombinant plasmid, and Doug Hanahan studies induced transformation.